RE:RE:9 more sitesCancerSlayer wrote: Per the article:
"We are approximately halfway through enrollment, with 11 clinical study sites currently enrolling patients and plans to add up to an additional nine clinical study sites in 2023 for a total of up to 20 clinical study sites in Canada and the United States,” according to Dr. Mandel.
Good point Dawg....Having limited cash on hand & yet still planning to add "9" additional sites hints at one likely event....& so I'm hopeful for seeing much more than a BTD/AA this year. As skys1 stated, Big Pharma has likely shown its hand & if all goes smoothly, I wouldn't be surprised to see a solid partnership unfold in the next 12 months. Good luck....
If they do get AA, then I would think big pharma would be competing with each other much faster than the 12 month timeframe. But a year is a reasonable estimate. Let's hope for a quick approval in Q1. Icing would be if they get on the Frontrunner bandwagon for trying this treatment as a first line of defense, given the BCG shortage and safety profile in addition to efficacy.